Hetero Labs gets CDSCO Panel nod to study Tegoprazan tablet 50 mg Dr. Divya Colin13 May 2025 5:45 PM ISTNew Delhi: Responding to the proposal presented by Hetero Labs, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Sun Pharma Gets CDSCO Panel Nod To study Semaglutide solution for Injection Dr. Divya Colin19 April 2025 6:00 PM ISTNew Delhi: Considering the bioequivalence (BE) study report of the antidiabetic drug Semaglutide solution for injection (synthetic origin) 0.25mg...
Cipla gets CDSCO Panel nod for Phase-III CT of Inhaled Itraconazole dry powder for inhalation 10 mg capsules Dr. Divya Colin15 April 2025 6:00 PM ISTNew Delhi: Accepting the phase II clinical trial results of inhaled itraconazole dry powder for inhalation 10 mg capsules (PUR1900) presented by the...
Submit Phase III CT data with Pk and Pd data: CDSCO Panel Tells Intas Pharmaceuticals on Human von Willebrand Factor Dr. Divya Colin12 April 2025 5:30 AM ISTNew Delhi: In response to the proposal for the grant of permission to manufacture Human von Willebrand Factor EP 600 IU (Freeze Dried Powder) Drug...
Intas Pharmaceutical Gets CDSCO Panel Nod To Conduct Phase III clinical trial of Fibrogen-I Dr. Divya Colin10 April 2025 6:15 PM ISTNew Delhi: Intas Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Novartis Healthcare Gets CDSCO Panel Nod To study Anti-cancer Drug Asciminib Dr. Divya Colin6 April 2025 3:30 AM ISTNew Delhi: Pharmaceutical major Novartis Healthcare has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug...
Sun Pharma Laboratories Gets CDSCO Panel Nod To study Esaxerenone Tablets Dr. Divya Colin26 March 2025 6:00 PM ISTNew Delhi: Sun Pharma Laboratories has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Pfizer Gets CDSCO Panel Nod To Study Anticancer Drug Disitamab vedotin Dr. Divya Colin22 March 2025 6:00 PM ISTNew Delhi: Citing that more geographically distributed government sites shall be included in the study, the Subject Expert Committee (SEC) functional...
Modify Phase III CT protocol: CDSCO panel Tells Windlas Biotech on FDC Tamsulosin plus Mirabegron Dr. Divya Colin14 March 2025 4:00 PM ISTNew Delhi: Responding to the revised Phase III clinical trial protocol of fixed dose combination (FDC) Tamsulosin plus MirabegronIP 0.4 mg/0.4 mg +...
Hetero Healthcare Gets CDSCO Panel Nod To Conduct Phase III clinical trial of Tioconazole vaginal film 300 mg Dr. Divya Colin11 March 2025 5:45 PM ISTNew Delhi:Hetero Healthcare has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation...
Mylan Pharmaceutical Gets CDSCO Panel Nod To study Selatogrel Dr. Divya Colin11 March 2025 5:00 PM ISTNew Delhi: Mylan Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Sun Pharma Labs Gets CDSCO Panel Nod Phase-III clinical trial of Semaglutide solution for injection Dr. Divya Colin27 Jan 2025 6:00 PM ISTNew Delhi: Sun Pharma Labs has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
